Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.31 |
| ▸ | APP | P05067 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10108534 | 0.95 | ALOX5 (0.39) | L3MBTL1KDM4EATMLIMK1HSD17B10 | |
| SCHEMBL19129637 | 0.94 | KDM4E (0.35) | L3MBTL1KDM4EATMLIMK1HSD17B10 | |
| SCHEMBL10108543 | 0.93 | ALOX5 (0.40) | L3MBTL1KDM4EATMLIMK1HSD17B10 | |
| SCHEMBL10108530 | 0.90 | ALOX5 (0.35) | ALOX5 | |
| SCHEMBL17426414 | 0.90 | L3MBTL1 (0.38) | L3MBTL1KDM4EATMHSD17B10KMT2A | |
| SCHEMBL31791 | 0.89 | ALOX5 (0.40) | L3MBTL1KDM4EATMHSD17B10APP | |
| SCHEMBL10108480 | 0.89 | ALOX5 (0.36) | L3MBTL1KDM4EATMALOX5 | |
| SCHEMBL15582836 | 0.88 | LIMK1 (0.33) | L3MBTL1KDM4EATMLIMK1APP | |
| SCHEMBL10108647 | 0.88 | ALOX5 (0.41) | HSD17B10ALOX5 | |
| SCHEMBL10108453 | 0.88 | L3MBTL1 (0.38) | L3MBTL1KDM4EATMHSD17B10KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4063466-A1 | ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE INCLUDING SAME | Samsung SDI Co., Ltd. (KR) | 2022-09-28 | — | — | EP | disclosed |
| EP-3243888-A1 | ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE INCLUDING SAME | Cheil Industries Inc. (KR) | 2017-11-15 | — | — | EP | disclosed |
| US-9246107-B2 | Compound for organic optoelectronic device, organic light emitting diode including the same and display device including the organic light emitting diode | CHEIL INDUSTRIES, INC. (KR) | 2016-01-26 | — | — | US | disclosed |
| US-9246107-B2 | Compound for organic optoelectronic device, organic light emitting diode including the same and display device including the organic light emitting diode | CHEIL INDUSTRIES, INC. (KR) | 2016-01-26 | — | — | US | disclosed |
| US-20150280136-A1 | ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2015-10-01 | — | — | US | disclosed |
| US-20150280136-A1 | ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2015-10-01 | — | — | US | disclosed |
| US-20120112174-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY DEVICE INCLUDING THE ORGANIC LIGHT EMITTING DIODE | CHEIL INDUSTRIES, INC. (KR) | 2012-05-10 | — | — | US | disclosed |
| US-20120112174-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY DEVICE INCLUDING THE ORGANIC LIGHT EMITTING DIODE | CHEIL INDUSTRIES, INC. (KR) | 2012-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120112174-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME AND DISPLAY DEVICE INCLUDING THE ORGANIC LIGHT EMITTING DIODE | AOX1, OCIAD1, OCIAD2 | L3MBTL1 2352/4885KDM4E 2197/4885ATM 3878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.